Acuren is trading 4.12% higher at $9.97 on October 27, 2026, with no clear company-specific catalyst identified in available news results. - Its next scheduled earnings release is November 5. - U.S. manufacturing activity strengthened. Reuters reported stocks opened higher as easing oil prices supported risk appetite ahead of earnings and the Federal Reserve decision. This broader context is not a confirmed direct cause of Acurenβs move.